Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Amany Hassan Saleh, Giza, Egypt
Wonkwag UH, Iksan, Jeollabukdo, Korea, Republic of
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Renmin Hospital of Wuhan University, Wuhan, Hubei, China
Ningxia Medical University Cardiovascular and Cerebrovascular Disease Hospital, Yinchuan, The Ningxia Hui Autonomous Region, China
Mona Mohamed Mogahed, Tanta, Elgharbia, Egypt
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, China
the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.